Difference between revisions of "Lung Density Biomarker Ctte"
Jump to navigation
Jump to search
(54 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
− | :Co-chairs: | + | :Co-chairs: Charles Hatt, PhD; Miranda Kirby, PhD |
− | : | + | :RSNA Staff Support: Julie Lisiecki |
* [http://tinyurl.com/QIBA-CT-Lung-Density-Roster Roster] | * [http://tinyurl.com/QIBA-CT-Lung-Density-Roster Roster] | ||
Line 16: | Line 16: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
− | *[[Media: | + | *[[Media:09 22 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|September 22, 2021]] |
− | *[[Media: | + | *[[Media:06 23 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|June 23, 2021]] |
− | *[[Media: | + | *[[Media:05 26 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|May 26, 2021]] |
− | *[[Media: | + | *[[Media:04 28 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|April 28, 2021]] |
− | *[[Media: | + | *[[Media:03 31 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|March 31, 2021]] |
− | *[[Media: | + | *[[Media:02 24 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|February 24, 2021]] |
− | *[[Media: | + | *[[Media:01 27 2021 QIBA CT Lung Density BC Call Summary-FINAL.pdf|January 27, 2021]] |
+ | |||
'''''[[Lung Density/COPD BC Call Summaries Archive]]''''' | '''''[[Lung Density/COPD BC Call Summaries Archive]]''''' | ||
Line 28: | Line 29: | ||
==Profile Development== | ==Profile Development== | ||
Status - <summarize current status> | Status - <summarize current status> | ||
− | * [[Media:QIBA_CT_Lung_Density_Profile_083017-Clean.docx | | + | |
+ | A Google link for Public Comment Resolution has been created for ease of sharing updates with the group: | ||
+ | https://docs.google.com/document/d/1uOzBaB_77vLSv8FKtQ59AxpfcAswtJ4t/edit#heading=h.gjdgxs | ||
+ | |||
+ | |||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_090420-clean.pdf | QIBA CT Lung Density Profile_09.04.2020, clean version]] (Contains Conformance Checklist, Appendix B) | ||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_090420-marked.pdf | QIBA CT Lung Density Profile_09.04.2020, with markup]] (Contains Conformance Checklist, Appendix B) | ||
+ | * [[Media:AAPM Comments QIBA CT Lung Densitometry final-SBF031620.pdf | AAPM Comments for CT Lung Density Profile]] | ||
+ | |||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_090319-clean.pdf | QIBA CT Lung Density Profile_09.03.2019]] (Contains Conformance Checklist, Appendix B) | ||
+ | * [[Media:checklist.pdf | QIBA CT Lung Density Profile Checklist, 09.03.2019]] (separate Conformance Checklist for ease of reference) | ||
+ | :*[[Media:QIBA CT Lung Density Protocols-Appendix E.xlsx|Appendix E:CT Lung Density Protocols 2019-06-26]] | ||
+ | |||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_062619-appendix-resolved.pdf | QIBA CT Lung Density Profile_06.26.2019]] (Distributed August 21, 2019) | ||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_062619.docx | QIBA CT Lung Density Profile_06.26.2019]] (for BC and CC votes to release) | ||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_042519.docx | QIBA CT Lung Density Profile_04.25.2019]] (for internal BC review) | ||
+ | * [[Media:QIBA_CT_Lung_Density_Protocols_Appendix_D_042519.xlsx | QIBA CT Lung Density Protocols, Appendix D_04.25.2019]] (for internal BC review) | ||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_022519.docx | QIBA CT Lung Density Profile_02.25.2019]] (for internal BC review) | ||
+ | |||
+ | * [[Media:QIBA_CT_Lung_Density_Profile_083017-Clean.docx | QIBA CT Lung Density Profile_08.30.2017]] (for internal BC review) | ||
* [[Media:QIBA_AirwayProfile.doc| QIBA Airway Profile 9/28/11 - (draft per Dr. Sean Fain)]] | * [[Media:QIBA_AirwayProfile.doc| QIBA Airway Profile 9/28/11 - (draft per Dr. Sean Fain)]] | ||
* [[Media:Profile_VerIowa_LungDensity_090611_BS.SF.doc|Lung Density QIBA Profile 9/6/11 v0.4 - (Iowa Version with comments)]] | * [[Media:Profile_VerIowa_LungDensity_090611_BS.SF.doc|Lung Density QIBA Profile 9/6/11 v0.4 - (Iowa Version with comments)]] | ||
Line 67: | Line 87: | ||
− | == | + | ==QIBA Funded Projects== |
+ | |||
+ | ====Round 2==== | ||
*[[University of Wisconsin]] | *[[University of Wisconsin]] | ||
+ | |||
+ | ====Round 4==== | ||
+ | *[[Media:Low CT Dose Lung Protocols for Repeatable Quantitative Measures in Multi-Center Studies.pdf | Project (Y) Low CT Dose Lung Protocols for Repeatable Quantitative Measures in Multi-Center Studies (University of Wisconsin, Madison)]] | ||
+ | |||
+ | ====Round 5==== | ||
+ | *[[Media:Investigation of Methods of Volume Correction for Lung Density CT.pdf | Project (L) Investigation of Methods of Volume Correction for Lung Density CT (University of Wisconsin, Madison)]] | ||
+ | |||
+ | ====Round 6==== | ||
+ | *[[Media:Translating Phantom Harmonization to Clinical Practice.pdf | Project (U) CT Lung Density Biomarker-Translating Phantom Harmonization to Clinical Practice (National Jewish Health)]] |
Revision as of 17:21, 4 October 2021
- Co-chairs: Charles Hatt, PhD; Miranda Kirby, PhD
- RSNA Staff Support: Julie Lisiecki
Scope
Scope: Quantitative CT lung densitometry and morphology for COPD and related diseases.
Initial Objectives:
- Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
- This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
- Compare the sensitivity of CT measurements to spirometry and other accepted measures.
- This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.
Recent Meetings/Call Summaries
- September 22, 2021
- June 23, 2021
- May 26, 2021
- April 28, 2021
- March 31, 2021
- February 24, 2021
- January 27, 2021
Lung Density/COPD BC Call Summaries Archive
Profile Development
Status - <summarize current status>
A Google link for Public Comment Resolution has been created for ease of sharing updates with the group: https://docs.google.com/document/d/1uOzBaB_77vLSv8FKtQ59AxpfcAswtJ4t/edit#heading=h.gjdgxs
- QIBA CT Lung Density Profile_09.04.2020, clean version (Contains Conformance Checklist, Appendix B)
- QIBA CT Lung Density Profile_09.04.2020, with markup (Contains Conformance Checklist, Appendix B)
- AAPM Comments for CT Lung Density Profile
- QIBA CT Lung Density Profile_09.03.2019 (Contains Conformance Checklist, Appendix B)
- QIBA CT Lung Density Profile Checklist, 09.03.2019 (separate Conformance Checklist for ease of reference)
- QIBA CT Lung Density Profile_06.26.2019 (Distributed August 21, 2019)
- QIBA CT Lung Density Profile_06.26.2019 (for BC and CC votes to release)
- QIBA CT Lung Density Profile_04.25.2019 (for internal BC review)
- QIBA CT Lung Density Protocols, Appendix D_04.25.2019 (for internal BC review)
- QIBA CT Lung Density Profile_02.25.2019 (for internal BC review)
- QIBA CT Lung Density Profile_08.30.2017 (for internal BC review)
- QIBA Airway Profile 9/28/11 - (draft per Dr. Sean Fain)
- Lung Density QIBA Profile 9/6/11 v0.4 - (Iowa Version with comments)
Protocol Development Activities
Groundwork Activities
Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.
- Phantom project
Working Documents
Reference Documents
- Quantitative Imaging in Lung Disorders Refresher Course Outline (Refresher Course at RSNA 2011: November 30th)
- 06-21-2011GammexBoxFullPath.ppt posted 6.23.2011
- 06-08-2011 COPDGeneModel2-GammexBox.ppt posted 6.8.2011
- Pulmonary Emphysema: Objective Quantification at Multi–Detector Row CT—Comparison with Macroscopic and Microscopic Morphometry Madani et al, Radiology: Volume 238: Number 3-March 2006
- Pulmonary Emphysema: Radiation Dose and Section Thickness at Multidetector CT Quantification—Comparison with Macroscopic and Microscopic Morphometry Madani et al, Radiology: Volume 243: Number 1-April 2007
- COPDGene protocol section
- ECLIPSE protocol description
- ECLIPSE CT protocol specifics
- Coxson's chairman summary
- Hoffman et al's paper on quantitative assessment
- Stoel et al's paper on volume correction
- Stoel et al's paper on longitudinal studies
- FDA Guidance for Industry - Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment